Grey Healthcare help GSK take top award
AUCKLAND, April 12, 2005
Grey Healthcare’s innovative campaign for Cartia® has helped GSK Consumer Healthcare’s New Zealand office carry off a
prestigious award at GSK’s Global 2004 Pyramid Awards.
The Pyramid Awards recognise marketing and business innovation and excellence throughout GlaxoSmithKline’s global
network. Only 5 Pyramids were awarded this year. The Cartia campaign won “Best Compelling Professional Communications”
for its marketing communications program to doctors and pharmacists.
Cartia is New Zealand’s leading brand of low dose aspirin and is used primarily as an aid to reduce the risk of heart
attacks and stroke. The campaign uses unique caricatures to highlight the major risk factors for heart disease and
encourages healthcare professionals to conduct risk assessments on their patients prior to their first cardiac event
based on evidence of the existence of these risk factors.
The campaign was developed for GSK by Grey Healthcare, Grey’s specialist healthcare consultancy practice and its
recognition came as no surprise to Grey’s CEO, Peter Darroch. From Peter
“The Cartia campaign is a perfect example of how the integrated communications planning model is working at Grey to not
only create great campaigns but also achieve real business growth for our clients at a level which receives
international acclaim from one of the world’s biggest pharmaceutical networks”
ENDS
Cartia contains 100mg enteric coated aspirin. Use for the inhibition of blood clotting. Tablets should be swallowed
whole with water without crushing or chewing. Always read the label carefully & use strictly as directed. Contraindications: Hypersensitivity to aspirin, bleeding disorders, stomach ulcers. Adverse
events: Nausea and gastric irritation. GlaxoSmithKline Consumer Healthcare, Auckland, New Zealand. ® is a registered
trade mark of the GlaxoSmithKline group of companies.